Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Correa-Rotter

Showing results (71-80 of 75) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 75 results.
Journal of Human Hypertension|June 5, 2015
The effects of cinacalcet on blood pressure, mortality and cardiovascular endpoints in the EVOLVE trialT I Chang, S Abdalla, G M London, et al.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|June 25, 2024
Mind the gap in kidney care: translating what we know into what we doV A Luyckx, K R Tuttle, D Abdellatif, et al.
Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion|May 19, 2023
Acute Kidney Injury in Critical Care COVID-19 Patients on Invasive Mechanical Ventilation: The Potential Preventive Role of DexamethasoneJuan M Mejia-Vilet, Noemi Del Toro-Cisneros, Adrián E Caballero-Islas, et al.
Bone|February 1, 1996
Oral alendronate induces progressive increases in bone mass of the spine, hip, and total body over 3 years in postmenopausal women with osteoporosisJ P Devogelaer, H Broll, R Correa-Rotter, et al.
Arthritis and Rheumatism|February 24, 2001
Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: a randomized, double-blind, placebo-controlled extension trialJ D Adachi, K G Saag, P D Delmas, et al.
Pageof 8

Showing results (71-80 of 75) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 75 results.
Journal of Human Hypertension|June 5, 2015
The effects of cinacalcet on blood pressure, mortality and cardiovascular endpoints in the EVOLVE trialT I Chang, S Abdalla, G M London, et al.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|June 25, 2024
Mind the gap in kidney care: translating what we know into what we doV A Luyckx, K R Tuttle, D Abdellatif, et al.
Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion|May 19, 2023
Acute Kidney Injury in Critical Care COVID-19 Patients on Invasive Mechanical Ventilation: The Potential Preventive Role of DexamethasoneJuan M Mejia-Vilet, Noemi Del Toro-Cisneros, Adrián E Caballero-Islas, et al.
Bone|February 1, 1996
Oral alendronate induces progressive increases in bone mass of the spine, hip, and total body over 3 years in postmenopausal women with osteoporosisJ P Devogelaer, H Broll, R Correa-Rotter, et al.
Arthritis and Rheumatism|February 24, 2001
Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: a randomized, double-blind, placebo-controlled extension trialJ D Adachi, K G Saag, P D Delmas, et al.
Pageof 8